FDA approves first drug to prevent Type 1 diabetes
The Checkup by Singlecare
NOVEMBER 23, 2022
Food and Drug Administration (FDA) approved the first drug to delay the onset of Type 1 diabetes. Tzield received priority review from the FDA, a status given to drugs with the potential for “significant improvement” in the treatment, diagnosis, or prevention of a serious condition. 17, the U.S. That’s where Tzield comes in.
Let's personalize your content